| 词条 | Shantha Biotechnics |
| 释义 |
| name = Shantha Biotechnics Limited | logo = | vector_logo = | type = | genre = | foundation = 1993 | founder = Koduru Iswara Varaprasad Reddy | location = Medchal, Hyderabad (India) | key_people = K. I. Varaprasad Reddy (Chairman) Harish Iyer (CEO) | area_served = | industry = Biotechnology, Vaccines | products = recombinant DNA vaccines | revenue = | operating_income = | net_income = | num_employees = | parent = Sanofi | subsid = | owner = | homepage = Shanthabiotech.com }}Shantha Biotechnics is an Indian biotechnology company based in Hyderabad. It is the first Indian company to develop, manufacture and market recombinant human healthcare products in India. The company is a wholly owned subsidiary of Sanofi group.[1] HistoryThe genesis of Shantha Biotechnics, Ltd. can be traced back to the initiatives of Dr.K.I.Varaprasad Reddy and Khalil Ahmed. Varaprasad and Ahmed established the company in 1993 to produce cost-effective drugs to reach the common man at an affordable price, while maintaining International standards in quality.[1] The project originated as an R&D outfit at the Osmania University under the industry-university interactive programme in 1993, and later operated out of the Center for Cellular and Molecular Biology until an independent R&D facility was built. In 2006, the European biotech major Mérieux Alliance bought 60% stake in Shantha Biotechnics at a valuation of $175 million.[2] In 2009, the vaccine division of French pharmacological company Sanofi Pasteur acquired the stake held by Mérieux Alliance, valuing Shantha Biotech at Euro 550 million (over Rs 3,770 crore).[3] Over time, Sanofi acquired further stake in Shantha Biotechnics and in 2013, acquired 100% of the company.[4] ProductsDrugs developed by Shantha include SHANVAC-B, SHANFERON, SHANKINASE, SHANPOIETIN, pediatric combination vaccines Shantetra and Shan5, SHAN HIB-DPT, SHAN HIB, and SHANTT. Today, Shantha Biotechnics caters to major international markets including Asia-Pacific, Africa, CIS and Latin America in addition to international organisations like UNICEF and PAHO. Insuman Cartridges ProjectCM K.Chandrashekar Rao (KCR) laid stone foundation for Insuman Cartridges project in Medak district.[5] This project will be executed by Shantha Biotechnics Private limited. The Main object of the insuman cartridges Project is to produce Insulin at a lower cost and located at Medak district Telangana state.The Project Cost for 460 crore.[6] See alsoGenome ValleyReferences1. ^1 {{cite news | url=http://www.moneycontrol.com/news/cnbc-tv18-comments/shantha-biotech-to-launch-5-in-1-pediatric-vaccine-_685973.html |title=Shantha Biotech to launch 5-in-1 pediatric vaccine - CNBC-TV18 |publisher=Moneycontrol.com |date= |accessdate=2012-09-28}} 2. ^{{cite news | url= http://www.vccircle.com/news/health-care/2009/07/27/sanofi-aventis-takes-control-shantha-biotechnics|title=Sanofi-Aventis Takes Control Of Shantha Biotechnics |publisher=VCCircle |date= |accessdate=2015-09-19}} 3. ^{{cite news | author=Somashekar Mulugu | url=http://www.thehindubusinessline.com/companies/article2101029.ece |title=Business Line : Companies News : Top level changes at Shantha Biotechnics |publisher=Thehindubusinessline.com |date= |accessdate=2012-09-28}} 4. ^{{cite news | url= http://www.vccircle.com/news/health-care/2013/11/01/sanofi-infusing-122m-complete-buy-out-shantha-biotech-and-further|title=Sanofi infusing $122M to complete buy-out of Shantha Biotech and further expansion |publisher=VCCircle |date= |accessdate=2015-09-19}} 5. ^Details: CM KCR lays foundation stone for Insuman Cartridges project in Medak 6. ^Details: Insuman Cartridges Project External links
6 : Biotechnology companies of India|Manufacturing companies based in Hyderabad, India|Sanofi|Pharmaceutical companies established in 1993|Biotechnology companies established in 1993|1993 establishments in India |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。